Skip to main content

HOLLENCREST CAPITAL MANAGEMENT

Position in LLY — ELI LILLY & Co

CIK 1161722 NEWPORT BEACH, CA

Position in LLY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$921,162
+$214,779 QoQ
Shares Held
768
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#3,212
of 4,601 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Jun 30, 2026
CallValue
$119,943
CallShares
100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

HOLLENCREST CAPITAL MANAGEMENT holds $5,976,653 across 13 Drug Manufacturers - General names. LLY ranks #4 (15.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 LLY
ELI LILLY & Co
This page
768 $921,162

All Filings in LLY

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $119,943 100
2026-06-30 $921,162 768
2026-03-31 $91,977 100
2026-03-31 $706,383 768
2025-12-31 $802,786 747
2025-09-30 $640,920 840
2025-06-30 $675,852 867
2025-03-31 $1,055,512 1,278
2024-12-31 $978,896 1,268
2024-09-30 $2,919,172 3,295
2024-06-30 $1,215,925 1,343
2024-03-31 $1,159,160 1,490
2024-03-31 $77,796 100
2023-12-31 $1,970,852 3,381
2023-09-30 $1,787,568 3,328
2023-06-30 $1,562,641 3,332
2023-06-30 $46,898 100
2023-06-30 $46,898 100
2023-03-31 $1,141,528 3,324
2022-12-31 $768,264 2,100
2022-09-30 $337,576 1,044
2022-06-30 $302,505 933
2022-03-31 $247,137 863
2021-12-31 $232,853 843
2021-03-31 $308,065 1,649
2020-12-31 $282,806 1,675
2020-09-30 $247,932 1,675
2020-06-30 $276,642 1,685